PMDA drug package insert
太田胃散A〈錠剤〉
PMDA OTC drug · 株式会社太田胃散 · package insert Jan 9, 2026
Key facts
| Brand names | 太田胃散A〈錠剤〉 |
|---|---|
| Companies | 製造販売元／株式会社太田胃散 |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 錠剤 |
| OTC effect category | 制酸・健胃・消化・整腸を2以上標榜するもの |
| Package insert date | Jan 9, 2026 |
| PMDA document key | 180061_J0601002827 |
| PMDA company code | 180061 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: